1
Partnering with an outstanding
initiative in life sciences and
healthcare

2
Drugs
Patent Cliff
Pharma
Expenditure
Control
Higher
Barriers
of Entry
Interoperability
Lack of HCP’s
Digital Culture
Low success of
Internal R&D
results
M&A
Technology
Public Purchase
Beyond
the PILL
Patient
Empowerment
The life sciences and healthcare industry is
immersed in a period of transformation
Open Innovation is a tool to reinvent and to achieve better results
and to meet new business needs

3
THE BIOREGION OF CATALONIA:
A GROWING HEALTHCARE AND
LIFE SCIENCES ECOSYSTEM

4
Source: Biocat Directory (Feb. 2017)
871COMPANIES
95RESEARCH
ORGANIZATIONS
Excellence in research & a strong entrepreneurial
spirit: key drivers in the development of the BioRegion

5
BIOCAT:
BUILDING NOW WHAT THE
ECOSYSTEM NEEDS NEXT

6
Biocat dynamizes all the stakeholders of the
BioRegion to transform knowledge and technology
into economic growth, and to create a social impact
STRATEGY:
• SHARING KNOWLEDGE AND PROMOTING
THE BIOREGION
• ACCELERATING ENTREPRENEURSHIP AND
COMPANIES GROWTH
• TECHNOLOGY TRANSFER AND
VALORISATION
Biocat acts as a strategic agent
and catalyst of the Catalan
healthcare and life sciences
ecosystem
RESEARCH
COMPANIES
&
START-UPS
ADMINISTRATION
CAPITAL
TALENT
PROGRAMS
KEY ELEMENTS OF THE BIOREGION:

7
Our goals:
• Promote innovation within the healthcare sector (ecosystem programs)
• Train and provide talent to the life science sector
• Create startups with valuable products and business models
• Collaborate and scale the program at European level
• Position the BioRegion at international level
BIOCAT develops programs to accelerate
healthcare entrepreneurship
The talent development
initiative of Biocat to
accelerate healthcare
entrepreneurship

8
MOEBIO programs
Program to develop entrepreneurs
and future leaders in healthcare
innovation
Educational sessions covering key
aspects in healthcare, innovation,
management and
entrepreneurship
Program that facilitates the
acceleration of healthcare
innovations emerging from
academic labs into
commercialization
• Direct impact to Hospitals
• Indirect impact to all the
stakeholders
• Direct impact to Research and Tech
Transfer Offices
• 9 months full-time • Hours in a day • 12-week part-time
• 12 people • Last year: 40 different people • 8 teams
• Individuals who want to enter
healthcare & life sciences
• Entrepreneurs, managers and
executives of healthcare
organizations, students, recent
graduates and other professionals
• Researchers (in hospitals or in research
institutions) with a potential business
technology and early start-ups
• Partners: Stanford Biodesign / EIT
Health Program
• --
• Partners: CIMIT / EIT Health Program
(in process)
• Connect with local and international
ecosystems (Silicon Valley, Galway,
Stockholm and Oxford)
• Connect to local ecosystems
• Connect with local and international
ecosystem (Boston, France and
Holland)
• 2013 • 2014 • 2018

9
d·HEALTH BARCELONA:
A PROGRAM TO TRANSFORM
UNMET NEEDS INTO
INNOVATIVE MARKETABLE
SOLUTIONS

10
Inspired in the prestigious Stanford University’s Biodesign Fellowship, d·HEALTH
Barcelona is a 9-month Program which provides disruptive education, training
and mentorship to 12 multidisciplinary Fellows that experience a full cycle of
innovation in healthcare.
After a clinical immersion in a top hospital of Barcelona, fellows select the most
valuable unmet healthcare needs and transform them into innovative solutions,
through the biodesign methodology. They identify, invent and implement a viable
business proposition to be place in the market.
Fellows receive training in subjects such as design thinking or creative
leadership through classes taught by over 50 international experts. They also
benefit from the vibrant BioRegion ecosystem and are able to attend the most
interesting events to improve their learning process and network with other
entrepreneurs and KOL.
“Are you working on something that can change the world? Yes or no? For 99% of the people on the planet,
the answer is no, and the fact of the matter is, we should be” Larry Page - co-founder of Google
d·HEALTH Barcelona: Transforming real unmet
needs into innovative marketable solutions

11
BIODESIGN CREATIVE LEADERSHIPLEAN STARTUP
A process for identifying,
inventing and implementing
new products and services in
healthcare through innovative
approaches such as Design
Thinking
A customer-centric approach to
validate your business ideas with
customer experiments/tests before
scaling them
A transformative educational
approach to develop business
creativity, personal mastery
and enterprising leadership
Join a successful methodology to enrich medtech
innovation

12
2014
2015
2016
2017
(ONGOING EDITION)
ICT
(Thorax Institute)
Neonatology Functional
rehabilitation
ICMDiM
(Institute of Digestive
and Metabolic Diseases)
ICOF
(Institute Ophthalmology)
Cardiology
Functional
rehabilitation
Gynecology and
Obstetrics
ICNU
(Institute Nephrology and
Urology)
Functional
rehabilitation
Endocrinology
9 projects developed after the 3 first editions
The 5th edition of d·HEALTH Barcelona will start on January 2018

13
Every year our fellows impact +1,100 people (patients,
HCPs, management,…)
CLINIC HSJD GUTTMANN TOTAL KEY BENEFIT
HCPs 400 100 75 575
Introduction of innovation culture in the
department
HOSPITAL
MANAGERS
10 15 10 35 Innovation as a new corporate priority
PATIENTS &
STAKEHOLDERS
124 102 154 380
Their voice is heard and incorporated in
the product dev.
ENTREPRENEURS 10
Knowledge, contacts, experience, mistakes
transferred
FACULTY 65 Connections at the industry level
INVESTORS 5 Access to capital and dealflow
MENTORS 15
Knowledge and experience being
transferred.
RESEARCH
CENTERS
25
Technology Transfer. Licences from
patents hold by Research Centers
TECHNOLOGICAL
CENTERS
30 Prototyping. First proofs of concept.
This is the only way to CHANGE HEALTHCARE at a systemic level

14
Product: Solution for chronic constipation in the form of a
wearable medical device that simulates the techniques of
professional massage therapists
Current status: On the market. Company incorporated in
2014 (usMIMA)
Team: Institut Guttmann, 2013-2014
Both projects have obtained funding from H2020, through the SME
instrument. In total, the funds raised are 2.3 M €
Product: Medical device for anal incontinence
Current status: Product development. Company’s incorporation
expected for the end of 2016
Team: Hospital Clínic, 2015
Our success stories

15
Through over 3,000 unmet clinical needs and more
than 1,250 interviews, we are improving healthcare
at a systemic level

16
The teams develop a deep analysis on the final top 12 needs selected
Information included in the report:
 Definition of the problem (data on
prevalence, incidence…)
 Clinical impact (cost of the clinical
problem…)
 Analysis on the current solutions
(analysis of current treatments, risk and
benefits of each of them, unmet needs
of the current solutions, weaknesses of
the current treatments and potential
opportunities of innovation…)
 Stakeholder analysis
Discovering, understanding & reformulating
unmet clinical needs to transform them into
valuable knowledge

17
More than 70 experts from all over the world
collaborating with the program

18
More than 70 experts from all over the world
collaborating with the program

19
• 1ST Prize BIOEMPRENEDOR XXI (2014)
• 1ST Prize Biotecnología y Salud del Everis Award
(2015)
• “TOP 10 innovative startups with social impact in
Spain” by TEDx Binnenhof/European
Commission and ENISA (2015)
• “Seal of Excellence” of the European
Commission/Horizon 2020 (2016)
• Head start Proof of concept EIT Health Award
(2016)
• Unique Spanish company participating in
MassChallenge UK accelerator
Our companies are recognised both at national
and international level

20
1. Digitalhealth.careers (https://goo.gl/ygwx5P )
2. Mobile World Capital (https://goo.gl/NbqRai )
3. Tech EU (https://goo.gl/kZPIOD )
4. HealthStartup (https://goo.gl/My2y3z )
MOEBIO is ranked as one of the most important
accelerators in Europe

21
INSPIRED BY:
COLLABORATOR HOSPITALS:
PARTNERS 2016:
21
Partners
UNIVERSITY SPECIFIC DEGREE: INNOVATION FELLOWSHIP OF:
COLLABORATORS:

22
OTHER MOEBIO PROGRAMS
SHORT PROGRAMS
CRAASH

23
Short Programs: learn from the best of d·HEALTH
BARCELONA classes
MOEBIO Short Programs are educational programs of maximum 20 hours covering key
aspects in healthcare, innovation, management and entrepreneurship. Short programs are addressed
at professionals willing to broaden their skills set and acquire new practical knowledge about today’s
most pressing issues, and this over a short period of time.
Short programs are
addressed to…
Entrepreneurs, managers
and executives of healthcare
organizations, students,
recent graduates and other
professionals interested in
expanding their areas of expertise
to healthcare and
entrepreneurship
2017 edition:
1.Understanding Healthcare Systems
2.Update on the Life Sciences Industry
3.Entrepreneurship and Management
4.Medical Devices I: Product Development
5.Medical Devices II: Market access
Partners of d·HEALTH have access to some “exclusive” classes that are
not available to the general public

24
CRAASH: New Program coming in Spring 2018
CRAASH is a 10-week part time program in which teams composed of clinicians, technologists
and entrepreneurs that have developed potential healthcare innovations engage with experienced
HealthTech entrepreneurs. Team members will learn-by-doing, getting out of the lab to transform
technologies into viable business propositions.
CRAASH is addressed to…
8 teams of three members
(clinician, technologist and
entrepreneur) coming from top
academic and research
institutions
It blends the decades of experience from CIMIT's pioneering work
facilitating innovations and innovators
• Uncovering stakeholder needs and buying
dynamics
• Developing and validate value propositions and
business models
• Creating pitches to target funders
• Exploring new markets
In collaboration with:

25
CRAASH: A Boston successful program in our
ecosystem
Program
Refinement
Program
Feedback
Call for teams Biocat provides
feedback based on
CIMIT proposed
selection criteria
CIMIT evaluates
teams/projects
and final
selection of the
teams
3 days
Kickoff In-person
Session Barcelona
• Customer/Stakehol
der Interviewing
• Defining Clinical
Needs and the
Value Proposition
8 weeks
Weekly Web-Meeting
Sessions
Web-Meeting Structure
9:00am–11:00am
Part 1: 9:00 - 10:00 am
Team Presentations &
Feedback
(~15 minutes for each team)
Part 2: 10:00 - 11:00 am
Weekly Lecture
Topics/Discussions
3 days
Close-out In-person
Session Boston
• Team "Pitches“
• Feedback
Team
solicitation
Team
selection
Program
Delivery
Barcelona Virtual Boston

26
WHAT CAN WE DO FOR YOU?

27
Collaborate with MOEBIO d·Health Barcelona
BUSINESS
OPORTUNITIES
BRAND
RECOGNITION
TRAINING
• Priority access to innovative business opportunities (final solution)
• Right of first look to the top clinical needs identified during the program
(needs top 12 and top 50)
• Have a “business liaison” working closely with of one the teams
• Clinical setting knowledge: reinforce the company knowledge of the current
dynamics and future trends of the main clinical areas of the hospitals
• Meeting with the KOL professionals
• Training in innovative methodologies developed at the hospitals
• Exclusive access to a limited number of lessons/workshops of interest of the
company included in the d·HEALTH learning program
• 2 Invitations to attend 10 sessions of the training package opened to the
ecosystem: the Short Programs
• Visibility in all d·HEALTH marketing materials (website, leaflets, e-mailings,
social media, press releases and events)
Being part of a successful and reknowed program

28
Collaborate with MOEBIO CRAASH
BUSINESS
OPORTUNITIES
BRAND
RECOGNITION
• Priority access to healthcare innovations emerging from academic labs (in
Spain and Europe) selected after CIMIT due diligence process
• Have a industry veteran working closely with one the teams
• Healthtech setting knowledge: reinforce the company knowledge of the
some current dynamics and future trends in healthcare innovations from the top
research centers in Europe
• Gain access to the Leading Research Centers and top mentors from Boston and
Europe
• Visibility in all CRAASH marketing materials (website, leaflets, e-mailings,
social media, press releases and events)
Being part of a new and disruptive program for early R&D projects

29
FOLLOW US AT:
@moebiobarcelona
blog.moebio.org
es.linkedin.com/in/moebiobarcelona
www.facebook.com/moebiobarcelona
MORE INFORMATION AT:
WWW.MOEBIO.ORG
AN INITIATIVE OF: INNOVATION
FELLOWSHIP OF: